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Tree Man Syndrome 
By George Qiao 
 Imagine a condition in which lesions that grow on your appendages are so severe that you cannot 
use your hands and feet properly. Moreover, these lesions are large and painful, and prevent you from being 
able to perform daily activities. Surgery, a common answer for this condition, can temporarily control the 
growths, but the lesions continue to grow back after each surgical operation. Currently, there is no cure, and 
the treatments only offer a temporary fix. Therefore, you are faced with a lifelong condition that severely 
limits your ability to live a normal life. Though there are many debilitating diseases, few of them are not 
given much attention. For example, one extremely rare disease is Epidermodysplasia verruciformis (EV), or 
tree man syndrome, characterized by bark-like warts growing on the body.1 Although the exact number of 
cases of EV is uncertain, about 200 cases in the world have been reported thus far.2 
 Discovered in 1922, EV is an autosomal recessive disorder that increases one’s susceptibility to the 
human papilloma virus (HPV) and is characterized by lesions that resemble wood. Furthermore, EV in-
creases one’s risk of developing skin cancer.3  HPVs are non-enveloped, double-stranded DNA viruses re-
sponsible for many lesions and cancers, and are often sexually transmitted.4 They infect the stratified epi-
thelium of the epidermis, and do not lead to symptoms for most individuals, although some cases can in-
volve development of warts. For infected individuals who show symptoms but are not suffering from EV, 
the warts are not as vast in number as those in patients with the mutations associated with EV.5 
 Researchers have generally attributed EV to mutations in the EVER1 and EVER2 genes, also 
called TMC6 and TMC8, respectively. These genes code for transmembrane proteins of keratinocytes, 
which are epidermal cells targeted by HPV. The proteins bind to and form a complex with a zinc transporter 
protein called zinc transporter 1 (ZnT-1). The EVER-ZnT complex transports zinc from the cytoplasm into 
the endoplasmic reticulum of the cell, directly decreasing the amount of zinc in the cytoplasm and indirectly 
decreasing the amount of zinc in the nucleus.5,6  Zinc is an ion vital for the function of AP-1 transcription 
factors which promote expression of the HPV genome. The EVER-ZnT complex limits the activity of AP-1 
transcription factors by decreasing the concentration of zinc in the nucleus, thereby limiting the ability of 
HPV to replicate.7 A mutation in either of the genes EVER1 or EVER2 would prevent the proper function-
ing of the EVER-ZnT complex and allow the proliferation of HPV. With the mutation, HPV infection can 
lead to uncontrolled division of keratinocytes, resulting in bark-like warts, especially on the hands and feet.1 
Immunohistochemistry with antibodies specific for HPV can detect HPV infection in keratinocytes and is 
used to diagnose patients with EV.2 
 Several treatments exist to combat EV, although there still remains no cure. The condition can be 
treated with surgery, which can remove the growths. However, surgery only offers a temporary solution to 
the condition, as the warts often return after surgery. One man in Bangladesh suffering from EV underwent 
multiple surgical operations to remove his warts in 2016. Although the surgeries granted him the ability to 
use his hands and feet for a period of time, the warts returned. Since 2016, he has had 25 surgeries, and has 
not found a permanent solution to the condition.8,9 Other treatments include cryotherapy, interferons, and 
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retinoids, all of which also offer temporary solutions to the problem.9, 10  
 Further research on EV should be conducted so that the scientific community can come closer to a 
cure for this debilitating disease. One path to take is to determine different possible causes of EV. Despite the 
experiments performed to determine the role of the EVER genes, it is not certain that a mutation in these 
genes is the sole cause of EV. In a particular study involving 41 EV patients, mutations in the EVER genes 
were present in 75 percent of the patients but absent in the remaining 25 percent, suggesting that there are 
other possible causes of EV.6 Thus, more research should be conducted to identify alternative causes of the 
condition. If we can determine the different mechanisms of action of this disease, we can come closer to a 
cure by directly targeting those mechanisms. Hopefully, in the future, we can find a solution that can help 
end the suffering of those affected by the disease.  
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